Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

Transarterial Chemoembolization for Hepatocellular Carcinoma: Why, When, How?

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. It is principally associated with liver cirrhosis and chronic liver disease. The major risk factors for the development of HCC include viral infections (HBV, HCV), alcoholic liver disease (ALD,) and non-alcoholic fatty liver...

Full description

Bibliographic Details
Main Authors: Evgenia Kotsifa, Chrysovalantis Vergadis, Michael Vailas, Nikolaos Machairas, Stylianos Kykalos, Christos Damaskos, Nikolaos Garmpis, Georgios D. Lianos, Dimitrios Schizas
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Personalized Medicine
Subjects:
hepatocellular carcinoma
transarterial chemoembolization
cirrhosis
liverneoplasm
Online Access:https://www.mdpi.com/2075-4426/12/3/436

Internet

https://www.mdpi.com/2075-4426/12/3/436

Similar Items